Financials
- Market Capitalization 801.73 M
- Employee 170
- Founded 2002
- CEO N/A
- Website www.dbv-technologies.com
- Headquarter France
- FIGI BBG0076D3T39
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-18.26
ratio cours/chiffre d'affaires
474.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2596 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | +20.37% | -14.66% | 820.97 M USD | ||
| 2604 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.67 USD | -1.61% | -6.44% | +49.85% | +29.82% | 810.43 M USD | ||
| 2637 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +12.52% | +265.08% | 773.16 M USD | ||
| 2643 | AURA Aura Biosciences, Inc. - Common Stock | 7.40 USD | -3.90% | -5.13% | +5.56% | +18.40% | 767.42 M USD |